AETHLON MEDICAL INC (AEMD) Form 424B3 — Jul 7, 2026
Aethlon Medical is conducting a best-efforts offering of 263,000 shares of common stock and 5,370,009 pre-funded warrants, each accompanied by a warrant, at a combined price of $0.71 per unit. The company aims to raise maximum gross proceeds of $4.0 million, with approximately $3.74 million net to the company before expenses, to fund general corporate purposes and clinical trials. The transaction will significantly increase the company's outstanding shares from approximately 2.37 million to 8.00 million, resulting in substantial dilution for existing shareholders.
Key figures
- Gross Proceeds
- 4,000,000
- Offering Price
- 0.71
- Shares Offered
- 5,633,009
- Net Proceeds
- 3,740,000
- Common Warrants
- 5,633,009
- Pre Funded Warrants
- 5,370,009
- Placement Agent Fees
- 260,000
- Shares Outstanding After
- 8,003,569
- Shares Outstanding Before
- 2,370,560
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.